190 related articles for article (PubMed ID: 11603881)
1. Epidemiology, morbidity, and treatment of overweight and obesity.
Aronne LJ
J Clin Psychiatry; 2001; 62 Suppl 23():13-22. PubMed ID: 11603881
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing DA
J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
[TBL] [Abstract][Full Text] [Related]
3. Burden of disease associated with overweight and obesity among U.S. military retirees and their dependents, aged 38-64, 2003.
Kress AM; Hartzel MC; Peterson MR
Prev Med; 2005 Jul; 41(1):63-9. PubMed ID: 15916994
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
Limosin F; Gasquet I; Leguay D; Azorin JM; Rouillon F
Acta Psychiatr Scand; 2008 Jul; 118(1):19-25. PubMed ID: 18582344
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
[TBL] [Abstract][Full Text] [Related]
6. Weight gain in the treatment of mood disorders.
Aronne LJ; Segal KR
J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
[TBL] [Abstract][Full Text] [Related]
7. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
Jerrell JM; McIntyre RS; Tripathi A
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
[TBL] [Abstract][Full Text] [Related]
8. [Bodyweight in inpatients with schizophrenia].
Wetterling T; Pest S; Müssigbrodt H; Weber B
Psychiatr Prax; 2004 Jul; 31(5):250-4. PubMed ID: 15243875
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
Gaciong Z; Placha G
J Hum Hypertens; 2005 Sep; 19(9):737-43. PubMed ID: 15905888
[TBL] [Abstract][Full Text] [Related]
10. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive examination of health conditions associated with obesity in older adults.
Patterson RE; Frank LL; Kristal AR; White E
Am J Prev Med; 2004 Dec; 27(5):385-90. PubMed ID: 15556738
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus, hypertension and obesity--common multifactorial disorders in Saudis.
Warsy AS; el-Hazmi MA
East Mediterr Health J; 1999 Nov; 5(6):1236-42. PubMed ID: 11924118
[TBL] [Abstract][Full Text] [Related]
13. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
[TBL] [Abstract][Full Text] [Related]
14. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.
Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M
Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274
[TBL] [Abstract][Full Text] [Related]
15. Obesity paradox in patients with hypertension and coronary artery disease.
Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
[TBL] [Abstract][Full Text] [Related]
16. A study of cardiovascular risk in overweight and obese people in England.
de Lusignan S; Hague N; van Vlymen J; Dhoul N; Chan T; Thana L; Kumarapeli P
Eur J Gen Pract; 2006; 12(1):19-29. PubMed ID: 16945868
[TBL] [Abstract][Full Text] [Related]
17. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
Tirupati S; Chua LE
Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
[TBL] [Abstract][Full Text] [Related]
18. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
19. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: epidemiology and consequences.
Sacks FM
J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
